February 19, 2014 | Israeli company Neuronix, which developed an innovative treatment for Alzheimer’s disease, has raised $5.5 million from a private investor. Neuronix’s treatment is a combination of magnetic stimulation of the brain and cognitive training.
Related posts
Cloud Data-Securing Startup Raises $30M
February 01, 2023
Electronic Tampon Eliminates Yeast Infections
February 01, 2023
Humans Beat AI At Guessing People’s Ages
February 01, 2023
$10M For Cyber Company That Protects Small Businesses
January 31, 2023
Facebook comments